Mirum Pharmaceuticals (MIRM) Gross Profit (2023 - 2025)
Historic Gross Profit for Mirum Pharmaceuticals (MIRM) over the last 3 years, with Q3 2025 value amounting to $107.5 million.
- Mirum Pharmaceuticals' Gross Profit rose 5447.96% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $377.0 million, marking a year-over-year increase of 6896.55%. This contributed to the annual value of $255.2 million for FY2024, which is 8318.8% up from last year.
- According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Gross Profit is $107.5 million, which was up 5447.96% from $104.4 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Gross Profit ranged from a high of $107.5 million in Q3 2025 and a low of $26.6 million during Q1 2023
- Over the past 3 years, Mirum Pharmaceuticals' median Gross Profit value was $57.6 million (recorded in 2024), while the average stood at $63.2 million.
- Its Gross Profit has fluctuated over the past 5 years, first soared by 9306.51% in 2024, then skyrocketed by 5447.96% in 2025.
- Over the past 3 years, Mirum Pharmaceuticals' Gross Profit (Quarter) stood at $44.5 million in 2023, then surged by 72.08% to $76.6 million in 2024, then skyrocketed by 40.24% to $107.5 million in 2025.
- Its last three reported values are $107.5 million in Q3 2025, $104.4 million for Q2 2025, and $88.6 million during Q1 2025.